Penumbra Share Holder Equity 2014-2022 | PEN
Penumbra share holder equity from 2014 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
- Penumbra share holder equity for the quarter ending December 31, 2022 was $0.999B, a 4.71% increase year-over-year.
- Penumbra share holder equity for 2022 was $0.999B, a 4.71% increase from 2021.
- Penumbra share holder equity for 2021 was $0.954B, a 49.57% increase from 2020.
- Penumbra share holder equity for 2020 was $0.638B, a 31.34% increase from 2019.
Penumbra Annual Share Holder Equity
(Millions of US $) |
| 2022 |
$999 |
| 2021 |
$954 |
| 2020 |
$638 |
| 2019 |
$486 |
| 2018 |
$422 |
| 2017 |
$400 |
| 2016 |
$267 |
| 2015 |
$233 |
| 2014 |
$99 |
| 2013 |
$48 |
Penumbra Quarterly Share Holder Equity
(Millions of US $) |
| 2022-12-31 |
$999 |
| 2022-09-30 |
$974 |
| 2022-06-30 |
$970 |
| 2022-03-31 |
$959 |
| 2021-12-31 |
$954 |
| 2021-09-30 |
$685 |
| 2021-06-30 |
$673 |
| 2021-03-31 |
$650 |
| 2020-12-31 |
$638 |
| 2020-09-30 |
$620 |
| 2020-06-30 |
$623 |
| 2020-03-31 |
$488 |
| 2019-12-31 |
$486 |
| 2019-09-30 |
$467 |
| 2019-06-30 |
$454 |
| 2019-03-31 |
$437 |
| 2018-12-31 |
$422 |
| 2018-09-30 |
$409 |
| 2018-06-30 |
$425 |
| 2018-03-31 |
$415 |
| 2017-12-31 |
$400 |
| 2017-09-30 |
$384 |
| 2017-06-30 |
$373 |
| 2017-03-31 |
$373 |
| 2016-12-31 |
$267 |
| 2016-09-30 |
$254 |
| 2016-06-30 |
$248 |
| 2016-03-31 |
$238 |
| 2015-12-31 |
$233 |
| 2015-09-30 |
$229 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
|
| 2014-09-30 |
$0 |
| 2013-12-31 |
$48 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$10.582B |
$0.847B |
|
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|
